Keeping an eye on health markers like blood pressure, cholesterol levels, and blood sugar can help evaluate the success of semaglutide treatment over time
This was the highest average increase observed across any dose group at any time point
While Novo Nordisk and Lilly seem best positioned now, emerging agents, oral options, dual/triple agonist molecules may capture niches or even displace certain uses of the first wave of GLP-1s
Retatrutide Raises the Bar Again Lilly also reported additional Phase 3 data for retatrutide, its next-generation triple-hormone obesity treatment
India has about 89.8 million adults living with diabetes, according to the International Diabetes Federations Diabetes Atlas 2024, a number projected to rise to 156.7 million by 2050
This protein helps your body repair damaged tissue